Zentek (TSXV:ZEN) EBIT per Share : C$-0.10 (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Zentek EBIT per Share?

Zentek's EBIT per Share for the three months ended in Dec. 2024 was C$-0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was C$-0.10.

During the past 3 years, the average EBIT per Share Growth Rate was -36.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -43.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was -8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zentek's EBIT per Share or its related term are showing as below:

TSXV:ZEN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -91.3 Med: -4.6 Max: 23
Current: -36.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Zentek was 23.00% per year. The lowest was -91.30% per year. And the median was -4.60% per year.

TSXV:ZEN's 3-Year EBIT Growth Rate is ranked worse than
88.5% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 6.2 vs TSXV:ZEN: -36.30

Zentek's EBIT for the three months ended in Dec. 2024 was C$-2.58 Mil.

Zentek EBIT per Share Historical Data

The historical data trend for Zentek's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentek EBIT per Share Chart

Zentek Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

-0.02

-0.05

-0.34

-0.14

-0.12

Zentek Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.02	-0.03	-0.03	-0.03

Zentek EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zentek's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-11.696	/	100.503
=	-0.12

Zentek's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.579	/	104.076
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.10

Zentek (TSXV:ZEN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zentek EBIT per Share Related Terms

Thank you for viewing the detailed overview of Zentek's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentek Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zentek Ltd (TSXV:ZEN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ZTEK:USA ZAY:Germany

Address

24 Corporate Court, Guelph, ON, CAN, N1G 5G5

Website

https://www.zentek.com

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Executives

Colin Stuart Van Der Kuur	Senior Officer
Francis Jacques Dubé	Director
Ilse Treurnicht	Director
John Snisarenko	Director
Brian Gerald Bosse	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Gregory Fenton	Director
Eric Wallman	Director